Co-Diagnostics, Inc. has 10 Schedule 13D or 13G filings on record since 2025-09-18. 1 holder's latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.99% | 559,706 | SCHEDULE 13G, 2026-08-14 | 2026-06-30 |
| Orca Capital AG | 3.7% | 2,248,182 | SCHEDULE 13G/A, 2025-10-30 | 2025-10-28 |
| The Vanguard Group | 3.54% | 1,705,952 | SCHEDULE 13G/A, 2025-10-30 | 2025-09-30 |
| Jane Street Group, LLC | 1.7% | 89,240 | SCHEDULE 13G/A, 2026-08-10 | 2026-06-30 |
| Ayrton Capital LLC | 0% | 0 | SCHEDULE 13G/A, 2026-02-11 | 2025-12-31 |
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-09-18 | Orca Capital AG | 9.9% | SCHEDULE 13G |
| 2025-09-19 | Orca Capital AG | 4.6% | SCHEDULE 13G/A |
| 2025-10-30 | The Vanguard Group | 3.54% | SCHEDULE 13G/A |
| 2025-10-30 | Orca Capital AG | 9.9% | SCHEDULE 13G/A |
| 2025-10-30 | Orca Capital AG | 3.7% | SCHEDULE 13G/A |
| 2025-11-13 | Ayrton Capital LLC | 9.7% | SCHEDULE 13G |
| 2026-02-11 | Ayrton Capital LLC | 0% | SCHEDULE 13G/A |
| 2026-06-03 | Jane Street Group, LLC | 6.4% | SCHEDULE 13G |
| 2026-08-10 | Jane Street Group, LLC | 1.7% | SCHEDULE 13G/A |
| 2026-08-14 | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
Tools for this story
Each opens in a new tab, filled in for Co-Diagnostics, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.